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ABSTRACT
Introduction: Breast cancer is the most prevalent
cancer among women. In Germany, women are invited
to a population-based mammography screening
programme for the first time at the age of 50. Since it is
still discussed whether the benefits of mammography
screening outweigh its harms, the concept of informed
choice has gained importance. The objective of this
cross-sectional study is to assess the proportion of
informed choices in the mammography screening
programme. A special focus is on the examination of
the impact of Turkish migration background and
educational level on informed choices.
Methods and analysis: The proportion of informed
choices is evaluated in a cross-sectional study with 3-
month follow-up for behavioural implementation of the
screening intention. A randomly selected sample of
17 000 women aged 50 years living in Westphalia-
Lippe, a region in the Federal State of North-Rhine
Westphalia, is invited to participate in this study. To
reach adequate numbers of Turkish women, all possibly
Turkish women in the sample are identified through a
name algorithm and contacted. The sample is drawn
from women registered in the study area for which the
registration offices consented to supply data for the
study (88% of all towns/cities in the study region).
Women identified through the Turkish name algorithm
received all materials in German and Turkish. The
primary outcome is informed choice. Data are collected
on informed choice components (knowledge, attitude,
decision/implementation) as well as on its possible
determinants (eg, health behaviour, perceived
behavioural control, subjective norms, invitation status,
migration background and other demographic
variables). Data are collected before the screening
appointment and at 3 months follow-up.
Ethics and dissemination: The study was approved
by the ethical committee of the Medical Faculty of
Muenster University. Results will be published in a
relevant scientific journal and communicated to
respondents and relevant institutions.
INTRODUCTION
Breast cancer is the most prevalent cancer
among women in Europe1 and in Germany.2
Population-based breast cancer screening
programmes have been implemented in
many European countries in the past
decades. In Germany, a nationwide mam-
mography screening programme has been
fully implemented since 2009.3 Women aged
50–69 years are invited to have a free mam-
mogram in a specialised centre every 2 years.
Currently there are about 10 million eligible
women in Germany.4
Mammography screening, like other screen-
ings, has both advantages and disadvantages.
The aims of the population-based mammog-
raphy screening programmes are the reduc-
tion of mortality from breast cancer and
improvement of recovery chances by early
detection and treatment.5 Mammography
screening has also negative implications such
as false-positive results, overdiagnosis and over-
treatment. In addition, negative psychological
outcomes such as anxiety or stress while
waiting for the result also play an important
role.6 7
As mammography screening affects healthy
women informed choice is crucial. According
to the European guidelines for quality assur-
ance in mammography screening, every
woman should know the beneﬁts and risks of
Strengths and limitations of this study
▪ Women receive the questionnaire close to the
time of receiving the official invitation letter.
Thus, the knowledge questions will reflect the
knowledge level at the time of the decision.
Intention as well as its implementation will be
observed.
▪ Women who intend to participate in mammog-
raphy screening may be more likely to participate
in the study as they are interested in the subject.
▪ Informed choice will be assessed among first-
time invitees and can be followed-up throughout
their screening history in future research.
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screening and make her decision for or against participa-
tion.5 An ‘informed choice’ is based on (1) sufﬁcient
knowledge, (2) personal attitudes and (3) an intention
and actual behaviour in accordance with these attitudes.8
Although the concept of informed choice competes with
the goal of a high participation rate (at least 70% to
assure quality and effectiveness of the screening),5 the
German Joint Federal Committee (Gemeinsamer
Bundesausschuss) and the German Mammography
Association (Kooperationsgemeinschaft Mammographie)
highlight its importance.
Previous studies from various European countries on
participation in mammography screening have mostly
focused on general determining factors. Age, income,
occupation, educational level, number of children,
housing property, place of residence and geographic dis-
tance to the screening are among the factors that have
been shown to have an inﬂuence on mammography
screening participation.9–11
Women with migration background are less likely to
participate in mammography screening than women of
the respective autochthonous population in several
European countries.12–18 In Germany, however, no such
difference could be found. In contrast, a slightly higher
proportion of women of Turkish origin seem to partici-
pate in mammography screening, compared to women
of all other origins (52% vs 49%).19
Studies on knowledge have identiﬁed poor knowledge
levels on mammography screening by the women con-
cerned. Gigerenzer et al20 found, that only 1.5% of all
women in Europe know the estimated reduction in
breast cancer mortality through regular attendance of
the screening. In Germany, women aged 44–63 tend to
overestimate the beneﬁts and underestimate the risks of
mammography screening.21 Age, educational level and
living area inﬂuenced the level of knowledge.21 In con-
trast, in the Netherlands 88% of the women aged
50 years make an informed choice to participate in
mammography screening, showing sufﬁcient knowledge
(deﬁned as 8 of 13 items answered correctly), a positive
attitude and an intention to participate.22
The primary aim of the InEMa study is to assess the pro-
portion of informed choice in the German population-
based mammography screening programme. The second-
ary aim is to examine the following hypotheses:
A. Turkish women make less informed choices than
autochthonous women do.
B. Women of lower educational level make less
informed choices than women of higher educational
level do.
METHODS AND ANALYSIS
The study is designed as a cross-sectional study with
follow-up for behavioural implementation of the screen-
ing intention investigating informed choice in women
invited for the national population-based mammography
screening programme for the ﬁrst time.
Study population and design
Women aged 50 years living in Westphalia-Lippe in the
Federal State of North-Rhine Westphalia in Germany will
be invited to participate in the study. Women from 88% of
all towns and cities in the study area could be included in
our database as the respective population registries pro-
vided complete data sets including address and date of
birth for our survey in 2012. The ﬁrst postal questionnaire
will be sent to the women 1–2 months after their 50th
birthday when they are also expected to receive their invi-
tation to the mammography screening programme by the
regional mammography organisation and thus have to
make a choice for or against screening participation.
The envelope comprises a cover letter, a consent form,
study information, the questionnaire and a prepaid
return-envelope. After the proposed screening appoint-
ment, participants will be sent a follow-up questionnaire
(3 month after the ﬁrst questionnaire, ﬁgure 1). This
allows assessing intention before screening appointment
as well as actual screening behaviour.
Data collection will be conducted between October
2013 and July 2014 (ﬁrst questionnaire) and January
and October 2014 (follow-up). The questionnaires will
be sent to women born between August 1963 and May
1964. The sample comprises 15 561 (54% of women in
the participating areas) month wise randomly selected
women without Turkish migration background. Women
with Turkish migration background will be oversampled
and all 1789 women with Turkish migration background
in the participating areas will be invited. Women with
possible Turkish migration background will be identi-
ﬁed by a name-based algorithm. As Turkish family
names have a meaning in the Turkish language and are
thus highly speciﬁc, this method allows identifying
women of Turkish origin in data sets without any other
migration-related variables such as place of birth or
nationality.23–25
Women with a possible Turkish migration background
will receive all materials in German and in Turkish. A
bilingual reminder postcard will be sent to all women
1 week after the initial send-out. Women can choose
between German and Turkish language for the follow-up
questionnaire. Completed questionnaires and written
consent for participation in our study will be returned
by mail.
A pretest among 300 women showed that procedures
are feasible. The questionnaire was adapted according
to the results.
Outcome measures
The primary outcome is informed choice. According to
the following three dimensions, a decision is classiﬁed as
informed or uninformed based on the classiﬁcation
model of Marteau et al8: knowledge (sufﬁcient/insufﬁ-
cient), attitude (positive/negative) and intention/imple-
mentation (yes/no). An informed choice is deﬁned as
having sufﬁcient knowledge and either having a positive
attitude towards mammography screening being
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congruent with the intention to participate and imple-
mentation or having a negative attitude in congruence
with no intention and implementation. A score of larger
than three (possible score range 0–7) is categorised as
having sufﬁcient knowledge. Questions on knowledge
were developed based on previous knowledge question-
naires of Mathieu et al26 and Marteau et al.8 The attitude
towards mammography screening is based on the
Reasoned Action Approach.27 A score of larger than or
equal to zero (possible score range −8 to +8) will be
categorised as positive attitude.
Further data will be collected about components and
determinants of informed choice, like health behaviour,
perceived behavioural control, subjective norms, invita-
tion status, migration background and other demo-
graphic variables as described in table 1.
Statistical analysis
Data will be entered in a MS Access form and analysed
using SPSS V.22.0 and MPlus. Five per cent of all ques-
tionnaires will be double-entered and data-entry quality
will be reported.
Women who have been diagnosed with breast cancer
will be excluded from the analyses. Women who already
participated in the screening programme will be
excluded as no intention to attend at the ﬁrst contact
can be assessed. Multiple imputation methods will be
applied to handle missing data.
Descriptive analyses to characterise the study popula-
tion and the proportion of informed choices and its
dimensions (knowledge, attitude and intention/partici-
pation) will be performed stratiﬁed by educational level
and (Turkish) migration background.
Univariate analyses, correlations (r2) and multivariate
methods (multiple regressions, moderator and mediator
analysis) will be performed to test the inﬂuence of edu-
cational level, (Turkish) migration status and other
factors on informed choice and its dimensions. Further
tests for differences in subgroups will be calculated (t
test, χ2 test). We will report results for single knowledge
items to assess the possible inﬂuence of the type of ques-
tion on the knowledge score. A non-responder analysis
will be performed.
For the components of the questionnaire, item, reli-
ability and factor analyses will be performed.
Sample size
Given an expected difference of 10% in informed
choice between subgroups, the study aims to recruit
5000 women to obtain a power of 0.80 with a conﬁdence
level of 95% with 20% exposed study participants (eg,
low level of education, migration background). To reach
adequate numbers of Turkish women, all Turkish
women in the sample will be contacted.
DISCUSSION
This study will provide estimates of informed choice for
or against participation in the mammography screening
programme in Germany among women invited for the
ﬁrst time. The ﬁndings will help to identify relevant sub-
groups with deﬁciencies in informed choices and other
participation-related patterns.
There are various risks of bias associated with the
study. We do not expect to have any selection bias as we
drew a randomly selected sample of women from
Westphalia-Lippe. However, it is expected that women
who intend to participate in mammography screening
are more likely to participate in the study as they are
interested in the subject. It is also likely that the most
deprived women such as low-literacy groups especially
among migrants will not respond to the questionnaire.
The proportion of migrants and low-literacy groups in
our study will be compared to those from the general
population (data from the statistical ofﬁce). Recall-bias
will be very low as women receive the questionnaire
close to the time of receiving the ofﬁcial invitation letter
and having to make the decision. The knowledge ques-
tions will reﬂect the knowledge level at the time of the
decision which is a strength of our study.
An important goal of our research is to raise awareness
for including informed choice as a standard concept in
studies analysing participation in mammography screen-
ing. The InEMa study will contribute to this goal by pro-
viding the ﬁrst empirical data about prevalence of
informed choice and its determinants in Germany, and
thereby help to further develop the biggest mammog-
raphy screening programme in Europe.
ETHICS AND DISSEMINATION
The study was approved by the ethical committee of the
Medical Faculty of Muenster University and the Data
Figure 1 Timeline of
mammography invitation and
study procedure.
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Protection Ofﬁcer of Bielefeld University. The second
questionnaire contains an α-numerical code to link the
two surveys. Individual data (names and addresses) are
stored separately from the questionnaire data. The ques-
tionnaire is not linked to the ofﬁcial invitation sent by
the mammography screening organisation. Women have
to give written consent to participate in the study.
We will publish the results on our main hypotheses as
well as several exploratory papers. The comprehensive
questionnaire developed and used in the study will be
published with data on its reliability, validity and factorial
structure of scales.
Acknowledgements The authors acknowledge support of the publication fee
by Deutsche Forschungsgemeinschaft and the Open Access Publication Funds
of Bielefeld University.
Contributors JS, E-MB and PK conceived and coordinated the study. E-MB
and MR wrote the first draft of the manuscript which was revised by all
authors. All authors have read and approved the final manuscript.
Funding This work was supported by the German Federal Ministry of Health
within Research for the National Cancer Plan, grant number NKP-332-028.
Competing interests None.
Ethics approval Ethical Committee of the Medical Faculty of Muenster
University.
Provenance and peer review Not commissioned; internally peer reviewed.
Table 1 Collected data
Topics Content of items Type of items
Intention/decision Intention to perform mammography screening in next
3 months, type of screening (program or elsewhere),
intention to participate in next invitational period*
3 multiple choice items
Confidence Confidence with the decision 1 item, 5-point Likert scale
Implementation of
decision
Performance of mammography screening in last
3 months*
1 multiple choice item
Attitude Important/not important, a good thing/a bad thing,
beneficial/harmful, comfortable/uncomfortable
4 semantic differentials items, 5-point Likert
scale, possible score range −8 to 8
Knowledge Target population, frequency and meaning of a
positive screening result, incidence and mortality
with or without screening program, false-negative
screening results and overtreatment
7 multiple choice items with one correct
answer, possible score range 0 (very poor
knowledge) to 7 (very good knowledge)
Self-rated knowledge 1 item, 5-point Likert scale, ranging from 1
(very good) to 5 (very poor)
Health status Self-rated health 1 item, 5-point Likert scale
Health behaviour Smoking status, previous mammography
performance, reason for previous mammography
(screening or diagnostic), performance of manual
breast self-examination, diagnostic mammography in
last 3 months*
5 multiple choice items
Screening behaviour Use of other screenings (gynaecological cancer
detection, skin cancer detection and health
check-up)
3 multiple choice items
Perceived
behavioural control
Feelings and expectations towards mammography
screening†
15 items, 5-point Likert scale
Role of others/
subjective norms
Advice to disadvice to participate or no advice by
gynaecologist, general practitioner, partner, relatives
and friends
5 items, 5-point Likert scale
Breast cancer Self-rated breast cancer risk, familial history of breast
cancer (mother or sister), own history of breast
cancer
3 items, multiple choice and 5-point Likert
scale
Demographic
variables
Partnership, highest educational level, size of
hometown, distance to screening unit, type of health
insurance, registration for prevention bonus program
of health insurance company
7 multiple choice items
Migration
background
Country of birth, duration of stay, German nationality,
language spoken at home
4 multiple choice items
German language
skills
Skills in reading, writing, speaking and listening 4 items, 5-point Likert scale
Invitation status Invitation for screening program received, time of
receipt
2 items, multiple choice and free text
Influence of the
questionnaire
Self-rated influence of questionnaire on decision 1 item, 5-point Likert scale
*Second questionnaire only.
†First and second questionnaire.
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